FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313231389> ?p ?o ?g. }

• W4313231389 endingPage "24" @default.
• W4313231389 startingPage "18" @default.
• W4313231389 abstract "Lipoglycopeptide antibiotics are semi-synthetic derivatives of glycopeptides and are characterized by a pronounced bactericidal activity against gram-positive pathogens. The aim of the study was comparative assessment of the sensitivity of gram-positive clinical isolates to lipoglycopeptide antibiotics (telavancin, dalbavancin, oritavancin). The following isolates were included in the work: methicillin-resistant Staphylococcus aureus (MRSA, n=780), methicillin-resistant coagulase-negative Staphylococcus spp. (MRCoNS, n=163), and vancomycin-resistant Enterococcus faecium (VREf, n=93). Serial dilutions were used to assess sensitivity with the addition of 0.002% polysorbate 80 to the medium. Lipoglycopeptides showed more pronounced antibacterial activity against MRSA compared to vancomycin, teicoplanin, and daptomycin, and had a MIC₅₀/MIC₉₀ (µg/ml): for telavancin — 0.06 /0.125, for dalbavancin — 0.016/0.06, and for oritavancin — 0.06/0.125. A trend towards an increase in the MIC of lipoglycopeptides and daptomycin was established in MRSA with the MIC of 2 µg/ml for vancomycin, the proportion of which was 13%. For MRCoNS, MIC₅₀ and MIC₉₀ of lipoglycopeptides did not exceed 0.06 µg/ml and 0.125 µg/ml, respectively. Oritavancin showed strong activity against VREf at MIC range of 0.03 µg/ml to 0.5 µg/ml, and at MIC₉₀ of 0.25 µg/ml. Thus, lipoglycopeptide antibiotics are a plausible alternative to vancomycin and daptomycin; they are characterized by pronounced activity and can be used to treat severe forms of staphylococcal infections." @default.
• W4313231389 created "2023-01-06" @default.
• W4313231389 creator A5018167410 @default.
• W4313231389 creator A5021836710 @default.
• W4313231389 creator A5037020556 @default.
• W4313231389 creator A5037145668 @default.
• W4313231389 creator A5044470718 @default.
• W4313231389 creator A5054068988 @default.
• W4313231389 creator A5054593033 @default.
• W4313231389 creator A5058993667 @default.
• W4313231389 creator A5065585046 @default.
• W4313231389 creator A5074465281 @default.
• W4313231389 creator A5076047511 @default.
• W4313231389 creator A5082853479 @default.
• W4313231389 creator A5083783853 @default.
• W4313231389 date "2022-12-28" @default.
• W4313231389 modified "2023-10-01" @default.
• W4313231389 title "Comparative Activity of Lipoglycopeptide Antibiotics Against Gram-Positive Bacteria" @default.
• W4313231389 cites W1548559854 @default.
• W4313231389 cites W2065763760 @default.
• W4313231389 cites W2102773481 @default.
• W4313231389 cites W2124955503 @default.
• W4313231389 cites W2135114811 @default.
• W4313231389 cites W2168765004 @default.
• W4313231389 cites W2262983945 @default.
• W4313231389 cites W2272121892 @default.
• W4313231389 cites W2641865946 @default.
• W4313231389 cites W2743342606 @default.
• W4313231389 cites W2744274169 @default.
• W4313231389 cites W2768209410 @default.
• W4313231389 cites W2777806867 @default.
• W4313231389 cites W2785104789 @default.
• W4313231389 cites W2786463718 @default.
• W4313231389 cites W2890810767 @default.
• W4313231389 cites W2898922831 @default.
• W4313231389 cites W2905988983 @default.
• W4313231389 cites W2941189307 @default.
• W4313231389 cites W3005631496 @default.
• W4313231389 cites W3020925562 @default.
• W4313231389 cites W3038009268 @default.
• W4313231389 cites W3039617618 @default.
• W4313231389 cites W3207039013 @default.
• W4313231389 cites W4200184598 @default.
• W4313231389 doi "https://doi.org/10.37489/0235-2990-2022-67-9-10-18-24" @default.
• W4313231389 hasPublicationYear "2022" @default.
• W4313231389 type Work @default.
• W4313231389 citedByCount "0" @default.
• W4313231389 crossrefType "journal-article" @default.
• W4313231389 hasAuthorship W4313231389A5018167410 @default.
• W4313231389 hasAuthorship W4313231389A5021836710 @default.
• W4313231389 hasAuthorship W4313231389A5037020556 @default.
• W4313231389 hasAuthorship W4313231389A5037145668 @default.
• W4313231389 hasAuthorship W4313231389A5044470718 @default.
• W4313231389 hasAuthorship W4313231389A5054068988 @default.
• W4313231389 hasAuthorship W4313231389A5054593033 @default.
• W4313231389 hasAuthorship W4313231389A5058993667 @default.
• W4313231389 hasAuthorship W4313231389A5065585046 @default.
• W4313231389 hasAuthorship W4313231389A5074465281 @default.
• W4313231389 hasAuthorship W4313231389A5076047511 @default.
• W4313231389 hasAuthorship W4313231389A5082853479 @default.
• W4313231389 hasAuthorship W4313231389A5083783853 @default.
• W4313231389 hasBestOaLocation W43132313891 @default.
• W4313231389 hasConcept C2776703206 @default.
• W4313231389 hasConcept C2778651397 @default.
• W4313231389 hasConcept C2778980435 @default.
• W4313231389 hasConcept C2779489039 @default.
• W4313231389 hasConcept C2780585763 @default.
• W4313231389 hasConcept C2781336494 @default.
• W4313231389 hasConcept C501593827 @default.
• W4313231389 hasConcept C523546767 @default.
• W4313231389 hasConcept C54355233 @default.
• W4313231389 hasConcept C71924100 @default.
• W4313231389 hasConcept C86803240 @default.
• W4313231389 hasConcept C89423630 @default.
• W4313231389 hasConceptScore W4313231389C2776703206 @default.
• W4313231389 hasConceptScore W4313231389C2778651397 @default.
• W4313231389 hasConceptScore W4313231389C2778980435 @default.
• W4313231389 hasConceptScore W4313231389C2779489039 @default.
• W4313231389 hasConceptScore W4313231389C2780585763 @default.
• W4313231389 hasConceptScore W4313231389C2781336494 @default.
• W4313231389 hasConceptScore W4313231389C501593827 @default.
• W4313231389 hasConceptScore W4313231389C523546767 @default.
• W4313231389 hasConceptScore W4313231389C54355233 @default.
• W4313231389 hasConceptScore W4313231389C71924100 @default.
• W4313231389 hasConceptScore W4313231389C86803240 @default.
• W4313231389 hasConceptScore W4313231389C89423630 @default.
• W4313231389 hasIssue "9-10" @default.
• W4313231389 hasLocation W43132313891 @default.
• W4313231389 hasOpenAccess W4313231389 @default.
• W4313231389 hasPrimaryLocation W43132313891 @default.
• W4313231389 hasRelatedWork W1975045523 @default.
• W4313231389 hasRelatedWork W2002500891 @default.
• W4313231389 hasRelatedWork W2009801005 @default.
• W4313231389 hasRelatedWork W2062867631 @default.
• W4313231389 hasRelatedWork W2163948114 @default.
• W4313231389 hasRelatedWork W2725360285 @default.
• W4313231389 hasRelatedWork W2756630929 @default.
• W4313231389 hasRelatedWork W2912936374 @default.

• next